ARCHIVES

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

This article is from The Cancer Letter archive.

Vol. 24 No. 29 | July 24, 1998

Download PDF Visit The Full Archive

Related Articles

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Quality Oncology Wins Pilot Contract For Cancer Management In Fla.

July 27, 2001

Huebner Retires, Named Scientist Emeritus

November 19, 1982